Jaber LA - Search Results

1

Evolution of peroxisome proliferator-activated receptor agonists.

Chang F, Jaber LA, Berlie HD, O'Connell MB. Chang F, et al. Among authors: jaber la. Ann Pharmacother. 2007 Jun;41(6):973-83. doi: 10.1345/aph.1K013. Epub 2007 May 22. Ann Pharmacother. 2007. PMID: 17519293 Review.

2

Risk perception for developing diabetes among pharmacists.

Pinelli NR, Berlie HD, Slaughter RL, Jaber LA. Pinelli NR, et al. Among authors: jaber la. Ann Pharmacother. 2009 Jun;43(6):1050-6. doi: 10.1345/aph.1L692. Epub 2009 May 12. Ann Pharmacother. 2009. PMID: 19435966

3

Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review.

Berlie HD, Kale-Pradhan PB, Orzechowski T, Jaber LA. Berlie HD, et al. Among authors: jaber la. Ann Pharmacother. 2021 Nov;55(11):1386-1396. doi: 10.1177/1060028021999473. Epub 2021 Mar 4. Ann Pharmacother. 2021. PMID: 33657863 Review.

4

Diagnostic performance of HbA_1c for diabetes in Arab vs. European populations: a systematic review and meta-analysis.

Bertran EA, Berlie HD, Taylor A, Divine G, Jaber LA. Bertran EA, et al. Among authors: jaber la. Diabet Med. 2017 Feb;34(2):156-166. doi: 10.1111/dme.13118. Epub 2016 Apr 21. Diabet Med. 2017. PMID: 26996656 Review.

5

Quality of diabetes care in Arab Americans.

Berlie HD, Herman WH, Brown MB, Hammad A, Jaber LA. Berlie HD, et al. Among authors: jaber la. Diabetes Res Clin Pract. 2008 Feb;79(2):249-55. doi: 10.1016/j.diabres.2007.09.003. Epub 2007 Oct 18. Diabetes Res Clin Pract. 2008. PMID: 17949846

6

Health issues in the Arab American community. The use of glucose-lowering agents and aspirin among Arab Americans with diabetes.

Berlie HD, Hammad A, Jaber LA. Berlie HD, et al. Among authors: jaber la. Ethn Dis. 2007 Summer;17(2 Suppl 3):S3-42-S3-45. Ethn Dis. 2007. PMID: 17985450

7

Thiazolidinediones and the risk of edema: a meta-analysis.

Berlie HD, Kalus JS, Jaber LA. Berlie HD, et al. Among authors: jaber la. Diabetes Res Clin Pract. 2007 May;76(2):279-89. doi: 10.1016/j.diabres.2006.09.010. Epub 2006 Oct 18. Diabetes Res Clin Pract. 2007. PMID: 17055103

8

Does Dapagliflozin Affect Energy Intake and Appetite? A Randomized, Controlled Exploratory Study in Healthy Subjects.

Bertran E, Berlie HD, Nixon A, Jaber L. Bertran E, et al. Clin Pharmacol Drug Dev. 2019 Jan;8(1):119-125. doi: 10.1002/cpdd.461. Epub 2018 May 3. Clin Pharmacol Drug Dev. 2019. PMID: 29723443 Clinical Trial.

9

Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.

Pinelli NR, Cha R, Brown MB, Jaber LA. Pinelli NR, et al. Among authors: jaber la. Ann Pharmacother. 2008 Nov;42(11):1541-51. doi: 10.1345/aph.1L198. Epub 2008 Oct 28. Ann Pharmacother. 2008. PMID: 18957626

10

Aspirin dose for prevention of cardiovascular disease in diabetics.

Nowak SN, Jaber LA. Nowak SN, et al. Among authors: jaber la. Ann Pharmacother. 2003 Jan;37(1):116-21. doi: 10.1345/aph.1C101. Ann Pharmacother. 2003. PMID: 12503945 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page